GlassScriptPhysician profile
Herbert C Ruckle
NPI 1548360415
$3,461.15
in general payments reported to CMS, 2019-2025
14 companies · $1,570 in 2025
The $1,570 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2022: $121 · 2023: $728 · 2024: $375 · 2025: $1,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Travel and Lodging: $733 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.61 |
| Travel and Lodging | $733.07 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,455.39 | 2019-2025 | Da Vinci Surgical System |
| Teleflex LLC | $676.04 | 2025 | Barrigel |
| Edap Technomed INC | $530.58 | 2025 | |
| Calyxo, INC. | $200.46 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $106.22 | 2024 | |
| Cook Medical LLC | $102.31 | 2024 | Litho 150 |
| Immunitybio, INC. | $102.27 | 2025 | |
| Valencia Technologies Corporation | $101.66 | 2022-2024 | Ecoin Device Kit |
| Dendreon Pharmaceuticals LLC | $58.50 | 2024 | Provenge |
| Abbvie INC. | $39.68 | 2022 | |
| Boston Scientific Corporation | $33.55 | 2022-2023 | Advance Xp |
| Novo Nordisk INC | $20.21 | 2025 | Rivfloza |
| Cycle Pharmaceuticals INC | $19.37 | 2024 | Tiopronin |
| Stryker Corporation | $14.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Ruckle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.